May 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zscaler, Inc. (“Zscaler” or “the Company”) (NASDAQ: ZS). Investors who purchased Zscaler securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Zscaler has violated federal… read more
May 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Grace Therapeutics, Inc. (“Grace” or “the Company”) (NASDAQ: GRCE). Investors who purchased Grace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Grace has violated… read more
May 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ducommun Incorporated (“Ducommun” or “the Company”) (NYSE: DCO). Investors who purchased Ducommun securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ducommun has violated federal… read more
May 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Intuit Inc. (“Intuit” or “the Company”) (NASDAQ: INTU). Investors who purchased Intuit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Intuit has violated federal… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vital Farms, Inc. (“Vital Farms” or “the Company”) (NASDAQ: VITL). Investors who purchased Vital Farms securities prior to May 8, 2025, and continue to hold to the present, are encouraged to… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ImmunityBio, Inc. (“ImmunityBio” or “the Company”) (NASDAQ: IBRX). Investors who purchased ImmunityBio securities prior to January 19, 2026, and continue to hold to the present, are encouraged to obtain additional information… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Super Micro Computer, Inc. (“Super Micro” or “the Company”) (NASDAQ: SMCI). Investors who purchased Super Micro securities prior to February 2, 2024, and continue to hold to the present, are encouraged… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (NASDAQ: ATRA). Investors who purchased Atara securities prior to May 20, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rumble Inc. (“Rumble” or “the Company”) (NASDAQ: RUM). Investors who purchased Rumble securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rumble has violated federal… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR). Investors who purchased UP Fintech securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Futu Holdings Limited (“Futu” or “the Company”) (NASDAQ: FUTU). Investors who purchased Futu securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Futu has violated… read more
May 26, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sleep Number Corporation (“Sleep Number” or “the Company”) (NASDAQ: SNBR). Investors who purchased Sleep Number securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sleep… read more
May 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Doximity, Inc. (“Doximity” or “the Company”) (NYSE: DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Doximity has violated federal… read more
May 21, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sigma Lithium Corporation (“Sigma” or “the Company”) (NASDAQ: SGML). Investors who purchased Sigma securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sigma has violated… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Power Solutions International, Inc. (“Power Solutions” or “the Company”) (NASDAQ: PSIX). Investors who purchased Power Solutions securities prior to May 8, 2025, and continue to hold to the present, are encouraged… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gartner, Inc. (“Gartner” or “the Company”) (NYSE: IT). Investors who purchased Gartner securities prior to February 4, 2026, and continue to hold to the present, are encouraged to obtain additional information… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Aquestive Therapeutics, Inc. (“Aquestive” or “the Company”) (NASDAQ: AQST). Investors who purchased Aquestive securities prior to June 16, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nektar Therapeutics (“Nektar” or “the Company”) (NASDAQ: NKTR). Investors who purchased Nektar securities prior to February 26, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Eos Energy Enterprises, Inc. (“Eos Energy” or “the Company”) (NASDAQ: EOSE). Investors who purchased Eos Energy securities prior to November 5, 2025, and continue to hold to the present, are encouraged… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Soleno Therapeutics, Inc. (“Soleno” or “the Company”) (NASDAQ: SLNO). Investors who purchased Soleno securities prior to May 26, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apollo Global Management, Inc. (“Apollo” or “the Company”) (NYSE: APO). Investors who purchased Apollo securities prior to May 10, 2021, and continue to hold to the present, are encouraged to obtain… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TriSalus Life Sciences, Inc. (“TriSalus” or “the Company”) (NASDAQ: TLSI). Investors who purchased TriSalus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TriSalus has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or “the Company”) (NASDAQ: BRCB). Investors who purchased Black Rock Coffee securities are encouraged to obtain additional information and assist the investigation. The… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arm Holdings plc (“Arm Holdings plc” or “the Company”) (NASDAQ: ARM). Investors who purchased Arm Holdings plc securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Armstrong World Industries, Inc. (“Armstrong” or “the Company”) (NYSE: AWI). Investors who purchased Armstrong securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Armstrong has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Prestige Consumer Healthcare Inc. (“Prestige” or “the Company”) (NYSE: PBH). Investors who purchased Prestige securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Prestige has… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Certara, Inc. (“Certara” or “the Company”) (NASDAQ: CERT). Investors who purchased Certara securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Certara has violated federal… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Upwork Inc. (“Upwork” or “the Company”) (NASDAQ: UPWK). Investors who purchased Upwork securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Upwork has violated federal… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Regeneron Pharmaceuticals, Inc. (“Regeneron” or “the Company”) (NASDAQ: REGN). Investors who purchased Regeneron securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Regeneron has violated… read more
May 20, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Dominion Energy, Inc. (“Dominion Energy”) (NYSE: D) and NextEra Energy, Inc. (“NextEra”) (NYSE: NEE). Investors who purchased Dominion Energy and continue to hold to the present are encouraged to obtain additional information and assist the… read more